Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$3.3M
2 rounds on record
Latest round
$3.3M
Venture round · Aug 2019 · 7 yr ago
Team
11-50
employees, estimated range
Grants
$1.8M
1 grant · CORDIS
The money's age
Long since its last round
85 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 1, 2025 Won a grant $1.8M · CORDIS Aug 31, 2019 Raised a round Venture round $3.3M · SEC Form D 2018 Founded
Funding rounds
RoundDateAmountInvestorsSource
Grant Sep 2025 $1.8M — CORDIS
Venture round Aug 2019 $3.3M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Heartpoint Global Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Paul PriceExecutive Officer, DirectorSEC Form D
Seth BognerExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Pathfinder MedicalVenture round · 7 mo ago • Founded 2014
Pathfinder Medical is developing a novel electronic guidance system that will enable clinicians to connect blood vessels in a minimally…
CroiValve11-50 employees
Innovating a Better Way. CroíValve’s mission is to help patients suffering from tricuspid regurgitation with a new, minimally invasive…
CardiovoltFounded 2024
Cardiovolt.ai: Leading AI-ECG company providing AI heart insights and cardiovascular disease prediction. Clinically validated artificial…
BiVACORVenture round $9M · 2 yr ago • 51-200 employees • 7 roles
Replacing Hearts. Restoring Lives. HEART FAILURE Heart failure is a global epidemic affecting at least 26 million people worldwide, 6.2…
PacertoolFounded 2020 • 1-10 employees
Pacertool develops PaCRTool, a highly differentiated and proprietary solution to improve cardiac resynchronization therapy (CRT) in heart…
Verdiva BioSeries A $410M · 21 mo ago • 201-500 employees
Verdiva Bio is committed to developing next-generation therapies to help people living with obesity, cardiometabolic disorders, and related…

Overview

HeartPoint Global is developing investigational catheter-based technologies designed to provide minimally invasive alternatives for patients with limited therapeutic options in heart failure and congenital cardiovascular disease.

People

Paul Price
Executive Officer, Director
Seth Bogner
Executive Officer, Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Coral Gables United States
HQ
10-50 est. staff

Financials

Total raised
$5.1M
Latest round
Grant
Funding rounds
2
Funding rounds
Round Announced Amount
Grant 2025 $1.8M Details
Venture - Series Unknown 2019 $3.3M Details